Cargando…
PB1865: SINGLE-COUNTRY, MULTICENTER, RETROSPECTIVE, OBSERVATIONAL, DESCRIPTIVE COHORT STUDY OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH VENETOCLAX IN ARGENTINA (VENARG).
Autores principales: | Pagano Vilar, C., Pavlovsky, M. A., Tannuri, R. K., Enrico Mattos, A., Zerga, M., Guanchiale, L., Custidiano, R., Miroli, A., Higashigata, M., Figueroa, F., Pose Cabarcos, J., Real, J., Giordano, L., Miodosky, M., De Stefano, G., Federico, A., Klimovsky, E., Cugliari, M. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431381/ http://dx.doi.org/10.1097/01.HS9.0000850312.54074.5f |
Ejemplares similares
-
P1713: VENETOCLAX IN COMBINATION WITH OBINUTUZUMAB IN FIRST LINE CHRONIC LYMPHOCYTIC LEUKEMIA IN ARGENTINA: A COST-EFFECTIVENESS ANALYSIS
por: Kanevsky, D., et al.
Publicado: (2022) -
Retrospective Multicenter Real-Life Study on the First-Line Treatment of Classical Hodgkin Lymphoma in Argentina
por: Mahuad, Carolina, et al.
Publicado: (2022) -
P013: Outcomes of first-line treatment (FL) of classical Hodgkin lymphoma (cHL) in Argentina: a real life multicenter retrospective study
por: Laura, Korin, et al.
Publicado: (2022) -
Venetoclax resistance induced by activated T cells can be counteracted by sphingosine kinase inhibitors in chronic lymphocytic leukemia
por: Sarapura Martinez, Valeria J., et al.
Publicado: (2023) -
Yellow fever in South Wales, 1865.
por: Smith, C E, et al.
Publicado: (1986)